US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 93.190
  • +0.610+0.66%
Close Dec 13 16:00 ET
  • 93.240
  • +0.050+0.05%
Post 18:38 ET
5.92BMarket Cap-44.59P/E (TTM)

Blueprint Medicines Key Stats

Blueprint Medicines Q3 2024 Earnings Date

Currency:USDOct 30, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
127.47M
128.18M
+717.57K
Beat Est.
+125.34%
+126.61%
+0.56%
EPS
-0.97
-0.89
+0.08
Beat Est.
+55.82%
+59.55%
+8.44%
Buy

Dec 14, 2024

Blueprint Medicines Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 155.955M--
--2024/Q4-- / 145.316M--
Oct 30, 20242024/Q3128.184M / 127.466M--
Aug 1, 20242024/Q2138.157M / 103.938M--
May 2, 20242024/Q196.116M / 81.445M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 155.955M--
--2024/Q4-- / 145.316M--
Oct 30, 20242024/Q3128.184M / 127.466M--
Aug 1, 20242024/Q2138.157M / 103.938M--
May 2, 20242024/Q196.116M / 81.445M--

Unlock Free Earnings Estimates

Blueprint Medicines Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 14, 2024

Buy

  • Buy

    66.67%
  • Hold

    33.33%
  • Sell

    0.00%

Price Target

No Data